TTY BIOPHARM COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.1 TWD | -0.13% |
|
-0.65% | -5.35% |
| 30/05 | TTY Biopharm Company Limited Announces Change of Members of Audit Committee | CI |
| 30/05 | TTY Biopharm Company Limited Announces Change of Members of Sustainable Development Committee | CI |
Chart calendar TTY Biopharm Company Limited
756f8a1ff14f8.7KW-4hhFhZmk7VR27aInw18f0nau_UK1a1tfEuG4PZo.mMTXtl8ExPvXnjcDhdhXhhpRvibNrwzvHh8eSpT6av6kw-i7SHDGoZCfYA~61ab40dfc2fd8a30fa5867efb8f314ba
Upcoming events on TTY Biopharm Company Limited
Past events on TTY Biopharm Company Limited
| 30/05/2024 | Annual General Meeting |
| 07/05/2024 | April 2024 Sales and Revenue Release |
| 07/05/2024 | Q1 2024 Earnings Release |
| 09/04/2024 05:28 am | March 2024 Sales and Revenue Release |
| 08/03/2024 02:57 pm | Q4 2023 Earnings Release |
| 06/03/2024 02:23 pm | February 2024 Sales and Revenue Release |
| 06/02/2024 01:32 pm | January 2024 Sales and Revenue Release |
| 14/03/2023 | Q4 2022 Earnings Release |
| 05/08/2022 | Interim 2022 Earnings Release |
| 09/03/2022 | FY 2021 Earnings Release |
| 04/11/2021 | Q3 2021 Earnings Release |
| 05/08/2021 | Interim 2021 Earnings Release |
| 09/06/2021 06:30 am | Annual General Meeting |
| 12/06/2020 06:30 am | Annual General Meeting |
| 25/06/2019 06:30 am | Annual General Meeting |
| 25/06/2019 | Annual General Meeting |
| 22/11/2018 06:30 am | Extraordinary Shareholders Meeting |
| 20/06/2018 | Annual General Meeting |
| 17/08/2017 | Q3 2017 Earnings Release (Projected) |
| 16/06/2017 06:30 am | Annual General Meeting |
Past dividends on TTY Biopharm Company Limited
| 28/03/2024 | Annual 3.5 TWD |
| 30/03/2023 | Annual 3.4 TWD |
| 19/07/2022 | Annual 3 TWD |
| 14/09/2021 | Annual 4 TWD |
| 17/07/2020 | Annual 4 TWD |
| 12/07/2019 | Annual 4.5 TWD |
| 06/07/2018 | Annual 4.5 TWD |
| 10/07/2017 | Annual 3.8 TWD |
| 21/07/2016 | Annual 3.5 TWD |
| 06/07/2015 | Annual 2.5 TWD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 4 466 4 467 -0.02% | 4 222 4 192 0.7% | 4 536 4 474 1.39% | 5 062 5 000 1.24% | 5 506 5 421 1.56% | 5 650 |
|
EBITDA Million TWD | Released Forecast Spread | 1 381 1 461 -5.49% | 1 114 1 174 -5.06% | 1 308 1 358 -3.66% | 1 414 1 417 -0.19% | 1 573 1 755 -10.35% | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | 1 229 1 297 -5.24% | 957 1 059 -9.63% | 1 141 1 183 -3.57% | 1 228 1 254 -2.05% | 1 372 1 416 -3.08% | 1 524 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 1 203 1 448 -16.96% | 1 202 1 210 -0.7% | 1 087 1 124 -3.28% | 1 408 1 417 -0.64% | 1 419 1 525 -6.92% | 1 524 |
|
Net income Million TWD | Released Forecast Spread | 900 1 120 -19.64% | 924 930 -0.66% | 832 821 1.31% | 1 094 1 131 -3.26% | 1 129 1 189 -5.09% | 1 219 |
|
EPS TWD | Released Forecast Spread | 3,61 4,51 -19.87% | 3,71 3,74 -0.75% | 3,34 3,30 1.15% | 4,40 4,54 -3.08% | 4,53 4,78 -5.23% | 4,90 |
| Announcement Date | 15/03/20 | 19/03/21 | 09/03/22 | 14/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 1 037 1 033 0.38% | 1 166 1 138 2.38% | 1 326 1 193 11.21% | 1 533 1 526 0.45% | 1 166 1 160 0.54% | 1 262 1 265 -0.27% | 1 433 1 410 1.66% | 1 645 1 560 5.43% | 1 274 1 234 3.21% |
|
EBITDA Million TWD | Released Forecast Spread | 292 266 9.55% | 343 318 7.99% | 414 368 12.6% | 365 414 -11.86% | 295 321 -7.96% | ||||
|
EBIT Million TWD | Released Forecast Spread | 247 242 1.9% | 298 304 -2.22% | 369 316 16.75% | 315 362 -13.08% | 245 294 -16.59% | 334 376 -11.17% | 504 448 12.51% | 289 334 -13.58% | 310 275 12.69% |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 287 274 4.85% | 351 336 4.45% | 437 346 26.46% | 333 384 -13.2% | 293 315 -6.78% | 393 376 4.62% | 506 509 -0.65% | 227 334 -32.02% | 368 325 13.25% |
|
Net income Million TWD | Released Forecast Spread | 228 215 5.65% | 284 257 10.76% | 338 280 20.73% | 245 305 -19.78% | 239 253 -5.47% | 309 301 2.56% | 376 399 -5.56% | 205 267 -23.3% | 281 257 9.25% |
|
EPS TWD | Released Forecast Spread | 0,91 0,87 5% | 1,14 1,09 4.59% | 1,36 1,12 21.07% | 0,99 1,21 -18.18% | 0,96 1,02 -5.42% | 1,24 1,21 2.48% | 1,51 1,61 -5.92% | 0,82 1,08 -24.07% | 1,13 1,03 9.71% |
| Announcement Date | 13/05/22 | 05/08/22 | 04/11/22 | 14/03/23 | 11/05/23 | 10/08/23 | 03/11/23 | 14/03/24 | 10/05/24 |
More events
Past sector events for TTY Biopharm Company Limited
| 21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
| 14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4105 Stock
- Calendar TTY Biopharm Company Limited
